Author Archives: donttradeourlivesaway

Multi-billion dollar fine on Pakistan puts the spotlight on a secret court

Source: ISDS Bilateral 3rd September 2019 TRT | 21 August 2019 Multi-billion dollar fine on Pakistan puts the spotlight on a secret court by Saad Hasan The Reko Diq mine case shows the overreach of a secretive arbitration system. Last month, … Continue reading

Posted in ISDS | Leave a comment

The Drug Pricing Conundrum: Why Transparency Reforms Are Necessary to Make Healthcare Accessible

Source: News 18 26th August, 2019   While an intellectual property system that includes safeguards for early introduction of generics does reap price-lowering benefits for India, making transparency reforms part of its agenda will spotlight the mark-ups, production costs and the … Continue reading

Posted in Drug prices, Transparency | Leave a comment

FDA Approves New Treatment For Drug-Resistant TB; Activists Call For Affordable Access

Source: Health Policy Watch 21st August 2019   The US Food and Drug Administration (FDA) last week approved a tuberculosis (TB) treatment regimen containing a new drug, pretomanid, offering a shorter, more effective course of treatment for highly drug-resistant strains of TB, … Continue reading

Posted in Access to Medicins, Tuberculosis (TB) | Leave a comment

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

Source: Health Policy Watch 19th August, 2019   NEW YORK (August 14, 2019)—Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant … Continue reading

Posted in Tuberculosis (TB) | Leave a comment

Letter to PM on Info Service on Health Issues

Source: Third World Network 13th August, 2019   TWN Info Service on Health Issues (May19/03) 9 May 2019 Third World Network Shri J. P. Nadda Hon’ble Minister of Health and Family Welfare Room No. 348, ‘A’ Wing Nirman Bhavan, New Delhi-110011 … Continue reading

Posted in Access to Medicins, Tuberculosis (TB) | Leave a comment

Indian civil society pushes for ‘Government Use’ compulsory license on MDR-TB Drugs

Source: Lawyers collective 13th August, 2019   Survivors of drug resistant tuberculosis, health organisations and the TB community in India and across the globe have appealed to the Prime Minister of India to issue a government use compulsory license for two … Continue reading

Posted in Tuberculosis (TB) | Leave a comment

Civil Society letter to minimize injectables and scale up new drugs in drug-resistant tuberculosis (DR-TB) regimen

13th Aug, 2019   To, Dr. K.S. Sachdeva, Addl DDG, Central TB Division, MoHFW, NirmanBhawan, New Delhi – 110011 Mr. Sanjeeva Kumar, Additional Secy (Health), MoHFW, 254-A, NirmanBhawan, New Delhi – 110011 Prof. Vinod K. Paul, Member, NITI Aayog, Government … Continue reading

Posted in Tuberculosis (TB) | Leave a comment